Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global Animal Parasiticides Market is Anticipated to Reach a Value of US$ 13,064.7 Mn by 2026

Persistence Market Research
Posted on: 25 Nov 16

NEW YORK, November 25, 2016 /PRNewswire/ --

Persistence Market Research (PMR) delivers key insights on the global animal parasiticides market in its published report, titled "Global Market Study on Animal Parasiticides: Pharmacies and Drug Stores Distribution Channel Segment Expected to Register High Revenue Growth Through 2026." In terms of revenue, the global animal parasiticides market is estimated to register a promising CAGR of 5.9% over the forecast period, owing to numerous factors, about which PMR offers thorough insights and forecasts in this report. The global animal parasiticides market registered a value of US$ 6,976.2 Mn in 2015.

The prime factors powering the demand for animal parasiticides are increasing awareness about animal healthcare, increasing demand of animal derived food products, growing concern about foodborne diseases and zoonotic diseases, growth in adoption of companion animals and increase in animal healthcare expenditure. However, a growing preference for vegetarian food and diet and a stringent approval process for animal parasiticides coupled with restrictions on the use of parasiticides in food producing animals are the restraints affecting the global animal parasiticides market.

A key trend defining the market is that larger players are focused towards enhancing their geographical presence and expanding their customer base by entering into strategic mergers and acquisitions. Furthermore, huge investment from government organizations and private players for research and development activities is also a key trend of global animal parasiticides market.

View Report Overview and Research Methodology@ http://www.persistencemarketresearch.com/market-research/animal-parasiticide-market.asp

The market is segmented based on product type, animal type, distribution channel and region. Based on product type, the market is sub-segmented into Ectoparasiticides, Endoparasiticides and Endectocides. Among the product type segment, Endoparasiticides segment is expected to exhibit the highest revenue growth over the forecast period. The Endoparasiticides product type segment is expected to register a significant CAGR of 5.9% during the forecast period in terms of value. The Ectoparasiticides segment is projected to exhibit a CAGR of 5.7% over the forecast period in terms of value.

The market has also been segmented by animal type into food producing animals and companion animals. The food producing animals segment is expected to be the largest over the forecast period, with the segment witnessing a CAGR of 6.2% during the forecast period. One of the key growth drivers for animal parasiticides market is the growing concern about foodborne and zoonotic diseases.

View Report Table of Contents, Figures, and Tables@ http://www.persistencemarketresearch.com/market-research/animal-parasiticide-market/toc

This report assesses trends driving growth of each segment on the regional as well as country level and offers potential takeaways that could prove substantially useful to animal parasiticides manufacturers looking to enter the market. Western Europe market has been estimated to dominate the global animal parasiticides market, accounting for a maximum revenue share of the market by 2016 end. North America is expected to account for over 20.0% revenue share of the global animal parasiticides market by 2016 end. Among the emerging markets, APEJ is estimated to exhibit a significant CAGR of 6.4% over the forecast period, followed by the North America market, due to increasing awareness about animal healthcare and increasing demand for animal derived food products.

Some of the key players in the global animal parasiticides market include Sanofi S.A. (Merial), Ceva Sante Animlae, Virbac SA, Vetoquinol S.A., Eli Lilly and Company, Zoetis Inc., Merck & Co Inc., Bayer AG, Boehringer Ingelheim GmbH and Perrigo Co. plc. The report discusses individual strategies followed by these companies in terms of enhancing their product portfolio, creating new marketing techniques, mergers and acquisitions. The 'Competitive Landscape' is included to provide report audiences with a dashboard view and company share collectively.

Request Sample Report@ http://www.persistencemarketresearch.com/samples/7996

PMR Overview 

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact
Persistence Market Research
U.S. Sales Office:
305 Broadway, 7th Floor
New York City, NY 10007
United States
USA - Canada Toll-Free: 800-961-0353
Email: sales@persistencemarketresearch.com

Web: http://www.persistencemarketresearch.com

Follow us on LinkedIn: https://www.linkedin.com/company/persistence-market-research-&-consulting/

For more information:
www.prnewswire.com/news-releases/global-animal-parasiticides-market-is-anticipated-to-reach-a-value-of-us-130647-mn-by-2026-602971786.html

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 25/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.